Marketable Securities - Available-For-Sale	12 Months Ended
Dec. 31, 2016
Investments, Debt and Equity Securities [Abstract]
Marketable Securities - Available-For-Sale	NOTE 9 - MARKETABLE SECURITIES – AVAILABLE-FOR-SALE In May 2012, the Company acquired 2,052 shares of Facebook stock (FB) for $95,256 plus fees. During 2013, the Company sold 1,052 share leaving 1,000 shares held in a trading account. The value of these shares and all others purchased by the Company at December 31, 2016 and 2015 amounted to $115,388 and $106,144, respectively. A 2012 decrease in value, gave rise to an unrealized loss of $40,632 for the year ended December 31, 2012. The Company evaluated the prospects of its investments in relation to the severity and duration of the impairment. Based on that evaluation, the Company consider the shares to be other than temporarily impaired at December 31, 2012, and recorded loss on marketable securities in the statement of operations of $40,632. As of December 31, 2016, and 2015, the company recorded an unrealized gain on the market value of its marketable securities of $88,252 and $77,593, respectively. All unrealized gains in 2016 and 2015 have been recorded as an increase to the marketable securities and an increase to accumulated other comprehensive income in equity.

Marketable Securities - Available-For-Sale

12 Months Ended

Dec. 31, 2016

Investments, Debt and Equity Securities [Abstract]

Marketable Securities - Available-For-Sale

NOTE 9 - MARKETABLE SECURITIES – AVAILABLE-FOR-SALE

In May 2012, the Company acquired 2,052 shares of Facebook stock (FB) for $95,256 plus fees. During 2013, the Company sold 1,052 share leaving 1,000 shares held in a trading account. The value of these shares and all others purchased by the Company at December 31, 2016 and 2015 amounted to $115,388 and $106,144, respectively. A 2012 decrease in value, gave rise to an unrealized loss of $40,632 for the year ended December 31, 2012. The Company evaluated the prospects of its investments in relation to the severity and duration of the impairment. Based on that evaluation, the Company consider the shares to be other than temporarily impaired at December 31, 2012, and recorded loss on marketable securities in the statement of operations of $40,632. As of December 31, 2016, and 2015, the company recorded an unrealized gain on the market value of its marketable securities of $88,252 and $77,593, respectively. All unrealized gains in 2016 and 2015 have been recorded as an increase to the marketable securities and an increase to accumulated other comprehensive income in equity.